Equity Research, Broker Reports, and media content on THG PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about THG PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard
  • 13 Oct 21
FTSE drops as UK GDP numbers underwhelmed against backdrop of shortage fears and rising food prices
ftse-drops-as-uk-gdp-numbers-underwhelmed-against-backdrop-of-shortage-fears-and-rising-food-prices
  • 16 Sep 21
London's FTSE rises on back of cabinet reshuffle and encouraging US economic data
london-s-ftse-rises-on-back-of-cabinet-reshuffle-and-encouraging-us-economic-data
  • 12 Jan 21
Market Report: FTSE treads water as Covid-19 cases continue to surge and UK shopkeepers battle storm
market-report-ftse-treads-water-as-covid-19-cases-continue-to-surge-and-uk-shopkeepers-battle-storm
  • 12 Jan 21
Market Report: FTSE treads water as Covid-19 cases continue to surge and UK shopkeepers battle storm
market-report-ftse-treads-water-as-covid-19-cases-continue-to-surge-and-uk-shopkeepers-battle-storm

THG PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on THG PLC. We currently have 71 research reports from 2 professional analysts.

Latest News/RNS

(more news)
Date Source Announcement
19May22 18:46 RNS THG PLC - Statement Regarding Recent Press Speculation
19May22 18:31 RNS Candy Ventures Sarl - Statement re Possible Offer
09May22 15:00 RNS THG PLC - Notice of AGM
06May22 07:00 RNS THG PLC - Annual Report and Accounts 2021
03May22 07:00 RNS THG PLC - Block Listing Six Monthly Returns
03May22 07:00 RNS THG PLC - Total Voting Rights
21Apr22 07:00 RNS THG PLC - FY21 preliminary results and Q12022 trading update
Get free RNS email alerts

  • Frequency of research reports

     

  • Research reports on

    THG PLC

  • Providers covering

    THG PLC

  • 16 May 22
Kromek - Technology enabler for next generation medical imaging

Kromek is an enabling technology provider to the medical imaging market in particular. It is a commercial-stage company with two significant high growth opportunities: as a critical component supplier of cadmium zinc telluride (CZT) detectors to the advanced medical imaging market (next generation SPECT and CT modalities); and as a manufacturer of state-of-the-art radiation detectors to global government and Homeland Security agencies. High barriers to entry, given c.£130m invested since incepti

Companies: Kromek Group Plc
  • 16 May 22
Morning Note – 16 May 2022


Companies: Kromek Group Plc (KMK:LON)Synairgen plc (SNG:LON)
  • 20 May 22
Cenkos: Healthcare Sector - Ward Round

Weekly round-up of AIM-listed healthcare news. Venture Life Group, GENinCode, Kromek, Alliance Pharma, Polarean Imaging, Benchmark Holdings, Ondine Biomedical, Verici Dx, Faron Pharmaceuticals, Avacta Group, Abingdon Health, Open Orphan, Belluscura, Hutchmed (China), Oxford Biodynamics

Companies: ANIC RUA CREO GENI HEIQ IHC IXI IUG OPTI SBTX VAL VLG

  • 12 May 22
Cenkos: Concurrent Technologies Plc -- FY21 Final results update

FY21 revenues of £20.5m were 5.1% ahead of forecasts, with gross margin increased 2.2% to 55.9% and PBT up 17% to £3.5m. R&D is accelerating with a focus on increasing the product range at double the previous frequency and within half the time. Order in-take is strong, though revenues in FY22E will be affected by the widely reported electronic component availability. However, with this growing order in-take and significant balance sheet strength, Concurrent is strongly positioned to continue to

Companies: Concurrent Technologies Plc
  • 13 May 22
Cenkos: Healthcare Sector -- Ward Round

Weekly round-up of AIM-listed healthcare news. Agronomics, Eden Research, IXICO, HeiQ, Trellus Health, NetScientific, Circassia, 4basebio, Fusion Antibodies, Surgical Innovations Group, Yourgene Health, Abingdon Health, Verici Dx, Poolbeg Pharma, Omega Diagnostics

Companies: ANIC RUA CREO GENI HEIQ IHC IXI IUG OPTI SBTX VAL VLG

  • 20 May 22
Hybridan Small Cap Feast 20/05/22

Dish of the day Joiners: No Joiners Today. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business networking platform), that is developing the Blossom Database pursuant to a third party licensing arrangement. The Company also has an investment of 426,000 common shares in Awakn, a Canadian NEO Exchange listed psychedelics research and clinical group, with operations in th

Companies: YCA 7DIG BOOM DMTR EYE KIBO NFC RST SPSY

  • 29 Apr 22
Cenkos: Brave Bison Group Plc -- Charging Ahead

Brave Bison has released its full-year results in-line with previous guidance. The company has had a transformational year with the new management team putting the business on a firmly profitable path having turned a statutory profit in FY21A for the first time along with 50% revenue growth. They carried out their valuable acquisition of Greenlight, a UK digital advertising and technology firm, which broadened and complemented the Brave Bison offering. Today, the company have announced a further

Companies: Brave Bison Group Plc
  • 18 May 22
Morning Note – 18 May 2022


Companies: ARB D4T4 ORPH SPE

  • 09 May 22
LIBERUM: Cerillion* - Strong momentum into H2


Companies: Cerillion Plc
  • 17 May 22
FY22 AOP ahead of expectations

Having updated in April that FY22 revenues and operating profits were expected to be in line with consensus, Eckoh today updates that operating profits grew strongly in the period and will now be ahead of consensus. Revenues are expected to be in line. We suspect this means operating profits will be slightly above £5.0m compared to our forecasts of £4.9m. This de-risks our FY23 forecasts, where we are looking for AOP of £7.7m. We are forecasting FY23 AOP of £5.9m from the existing business, up f

Companies: Eckoh plc
  • 17 May 22
FY22 in line, further strong growth expected in FY23

Despite lingering lockdown headwinds, FYJan22 saw continued strong growth for Smartspace’s two SaaS businesses, SwipedOn (visitor, employee and desk management) and Space Connect (meeting room and desk management), driving combined ARR up 64% organic to £4.9m. SwipedOn ARR grew 57% yoy (>85% of total ARR) with Space Connect ARR up almost threefold. Encouraging trading through to end April (ARR rose to £5.5m) underpins Smartspace’s continued expectations for “further strong growth in FY23”. Key d

Companies: Smartspace Software Plc
  • 13 May 22
Hybridan Small Cap Feast 13/05/22

Dish of the day Joiners: GS Chain (GSC) has joined the Main Market (Standard). GS Chain intends to identify opportunities within the technology sector, to conduct the necessary due diligence and subsequently complete an Acquisition. The Company is direct listing 399,985,888 Ordinary Shares on the Official List. Market capitalisation at 1p is £3,999,858.88. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? According to CITY A.M online marketplace Beauty Bay has recruited bankers to lo

Companies: FPO NMT RBD SNT SOLG HUI FCRM AEX

  • 18 May 22
Hybridan Small Cap Feast 18/05/22

Dish of the day Joiners: Lekoil, the oil and gas exploration and production Company with a focus on Nigeria and West Africa has joined the Access Segment of the AQSE Growth Market. The Company was previously listed on AIM (LEK.L), however, Ordinary Shares have been suspended from trading on AIM since October 2021. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Psych Capital PLC, intends to list on the AQSE Growth Market. Psych operates the Psych Platform (a business-to-business ne

Companies: CZA AXL AEE CORA D4T4 EKF ORPH PWM PPH SYM

  • 06 May 22
LIBERUM: CMO Group* - 2021 accomplished, 2022 started well


Companies: CMO Group PLC
  • 11 May 22
1Spatial - Going to California with Caltrans on my mind

1Spatial continues its US expansion with the announcement of a contract win to support replacing the Transportation System Network (TSN) for the California Department of Transportation (Caltrans). The contract is worth c $1.4m over four years, including US$0.7m in software licence revenue, and was won in partnership with Rizing, a global SAP partner. The US market is a key growth engine for 1Spatial and the Caltrans win shows its strategic plan continues to bear fruit. This contract follows othe

Companies: 1Spatial Plc